TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 312 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q1 2021. The put-call ratio across all filers is 1.11 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $107,164,000 | -51.5% | 7,862,379 | -41.8% | 0.32% | -39.0% |
| Q3 2021 | $221,157,000 | -15.2% | 13,501,650 | -12.9% | 0.53% | +9.5% |
| Q2 2021 | $260,747,000 | -23.7% | 15,492,997 | -17.2% | 0.48% | -28.6% |
| Q1 2021 | $341,775,000 | +117.9% | 18,717,144 | +117.2% | 0.68% | +62.8% |
| Q4 2020 | $156,851,000 | +660.4% | 8,618,165 | +645.3% | 0.42% | +241.8% |
| Q3 2020 | $20,628,000 | – | 1,156,297 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TFG Asset Management GP Ltd | 1,903,662 | $29,449,652 | 5.37% |
| MANAGED ASSET PORTFOLIOS, LLC | 1,736,416 | $26,862,356 | 4.12% |
| Y.D. More Investments Ltd | 1,381,550 | $21,372,579 | 4.11% |
| Clean Yield Group | 533,157 | $8,167,965 | 3.62% |
| XY Capital Ltd | 143,697 | $2,222,993 | 1.28% |
| Mondrian Investment Partners LTD | 4,081,715 | $61,225,725 | 1.26% |
| Capricorn Fund Managers Ltd | 204,892 | $3,169,679 | 1.10% |
| Legacy Wealth Asset Management, LLC | 124,967 | $1,933,239 | 0.71% |
| HAP Trading, LLC | 263,679 | $4,079,114 | 0.65% |
| BRANDES INVESTMENT PARTNERS, LP | 1,802,036 | $27,877,493 | 0.54% |